article · Journal of Pharmaceutical Research International
Background: Essential oil (EO) of Cymbopogon citratus has been demonstrated to have antibacterial activities against both Gram negative and Gram positive bacteria. The study was, therefore, conducted to evaluate the effects of combined use of C. citratus and ciprofloxacin against fluoroquinolone-resistant Staphylococcus aureus (FQRSA) and Escherichia coli (FQREC).
 Methods: The antibacterial activity of the essential oil was evaluated by agar dilution method while the combination studies were done using Checker-board agar dilution technique.
 Results: The mean MIC values of EO against the FQRSA and FQREC were 0.043 + 0.01 mg/ml and 0.049 mg/ml respectively. When ciprofloxacin was combined with EO of lemongrass, 53.9, 28.3, 17.8 and 0.0 % of the FQRSA isolates showed indifference, additive, synergistic and antagonistic effects respectively. Similarly, when ciprofloxacin was combined with EO of lemongrass at different ratios, 44, 35.5, 20.6 and 0.0 % of the FQREC isolates showed combined effects of additivity, synergism, indifference and antagonism respectively.
 Conclusions: The results revealed the invitro antibacterial potency of Cymbopogon citratus oil against fluoroquinolone resistant S. aureus and E. coli. More importantly, the study has proved that the combined use of ciprofloxacin and essential oil of lemongrass has increased the sensitivity of both FQRSA and FQREC bacteria.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.9734/jpri/2023/v35i247425
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.